EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Iconic Worldwide Bhd (9113) fair value: what the stock is really worth

As of Sep 24, 2026: fair value of Iconic Worldwide Bhd MYR 0.03, price MYR 0.09, upside -66.9%, quality 37 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Healthcare · MY · ISIN MYL9113OO001

IW Thin data Sep 24, 2026

Iconic Worldwide Bhd

9113 · KLSE

Weakest SetupStrongly overvalued and low quality.

!Fair value 0.0298 MYR · Strongly overvalued (−67%)
!Quality 37/100
!Weak Growth (revenue 5y +14.4 %/yr)
!Loss over the last twelve months · -3.2% net margin (TTM) · fiscal year 2025 6.6%
!Low debt · negative free cash flow
!Trails peers (4/11)
!Narrow moat 20/100
!Evidence only low, so the estimate is less certain

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

0.4959 MYR 0.0600 MYR Fair Value 0.0298 MYR May 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range 0.0600 MYR – 0.4959 MYR · fair‑value band 0.0213 MYR – 0.0468 MYR · the 0.0900 MYR price screens above the 0.0298 MYR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.

Follow Iconic Worldwide Bhd in your weekly email

Every Wednesday you see whether Iconic Worldwide Bhd is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Iconic Worldwide Berhad, an investment holding company, engages in tourism and property businesses in Malaysia, Turkey, Hong Kong, Thailand, Philippines, the Middle East Indonesia, Australia, Thailand, and India.It operates through four segments: Property, Manufacturing, Hospitality services, and Others.

Show more

Iconic Worldwide Berhad, an investment holding company, engages in tourism and property businesses in Malaysia, Turkey, Hong Kong, Thailand, Philippines, the Middle East Indonesia, Australia, Thailand, and India.It operates through four segments: Property, Manufacturing, Hospitality services, and Others. The company develops and sells residential, commercial properties and undertakes management of car park operations. It also provides hospitality management and related services; operates as a hotelier; management services for hotels and residences; property investment; and manufactures, distributes, and deals in personal protective equipment products and related appliances, such as disposable face masks and gloves; and personal hygiene, and cosmetics related products. The company was formerly known as Sanbumi Holdings Berhad and changed its name to Iconic Worldwide Berhad in August 2019. Iconic Worldwide Berhad is based in Bukit Mertajam, Malaysia.

Stock analysis

Iconic Worldwide Bhd (9113) currently trades at 0.0900 MYR, while our model-based Fair Value estimate is 0.0298 MYR, implying the stock looks roughly 202.0% overvalued today.

Show more

Valuation

Bull case: the Asset-Based group reads highest at a median of 0.0700 MYR per share, and 0 of the 12 models we run sit above the 0.0900 MYR price.

Bear case: the Earnings-Based group reads lowest at 0.0100 MYR, and 12 of the 12 models stay below the price. Evidence for this calculation is low.

Scenario range: 0.0213 MYR (bear) to 0.0468 MYR (bull), the price of 0.0900 MYR sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 37/100 (below-average quality), in the Healthcare sector.

Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

Iconic Worldwide Bhd reported revenue of 47.4M MYR in FY2025 versus 49.2M MYR in FY2021, a compound −0.9%/yr. Reported net income was 3.1M MYR in FY2025, compounding −22.7%/yr from FY2021.

Key figures

Market cap 152M MYR (≈ $37.2M) · P/S ratio 1.90 · Net margin 6.6% · Return on equity −1.0% · Return on assets (EBIT) −6.4% · Operating margin −0.8% · Revenue (TTM) 57.7M MYR · Revenue growth (YoY) +28.2%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 42 out of 100 (low confidence).

What moves the price

The share trades at its 52-week high and 50% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −12% fair-value upside, at −67%, 9113 screens richer than that median.

Fair Value models

Bear 0.0213 MYR Fair Value 0.0298 MYR Bull 0.0468 MYR
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
Owner Earnings 0.0300 MYR 0.0400 MYR 0.0800 MYR 71
EPV 0.0100 MYR 0.0100 MYR 0.0200 MYR 70
Residual Income 0.0700 MYR 0.0700 MYR 0.0500 MYR 68
All 13 models by family
DCF Models
Owner Earnings 0.0300 MYR 0.0400 MYR 0.0800 MYR 71
Earnings-Based
Graham-Dodd 0.0100 MYR 0.0200 MYR 0.0300 MYR 63
EPV 0.0100 MYR 0.0100 MYR 0.0200 MYR 70
Multiples
P/E Multiple 0.0300 MYR 0.0400 MYR 0.0500 MYR 63
P/S Multiple 0.0200 MYR 0.0300 MYR 0.0400 MYR 57
P/B Multiple 0.0200 MYR 0.0300 MYR 0.0400 MYR 54
EV/EBIT 0.0300 MYR 0.0600 MYR 0.0800 MYR 64
EV/EBITDA 0.0300 MYR 0.0500 MYR 0.0700 MYR 65
EV/Revenue n/a n/a 0.0100 MYR 50
Asset-Based
NCAV (Graham) 0.0500 MYR 0.0700 MYR 0.1100 MYR 53
Economic Profit
Residual Income 0.0700 MYR 0.0700 MYR 0.0500 MYR 68
ROIC Compounder 0.0100 MYR 0.0100 MYR 0.0200 MYR 67
Growth Earnings
Growth-Adj P/E 0.0200 MYR 0.0300 MYR 0.0400 MYR 65

Open the full fair value analysis →

Notify me when 9113 reaches fair value

Put 9113 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 37/100

Of which business quality 35 · Market factors (momentum, volatility) 65

Profitability 17
Margins and returns on capital today
Quality Growth 49
Are margins and returns improving?
Cashflow 0
Earnings quality: real cash, not paper profit
Fin. Strength 40
Balance sheet, leverage, solvency risk
Investment 100
Disciplined investing over empire-building
Low Volatility 50
Calm price path (market factor)
Momentum 65
Price trend over the last 3–12 months (market factor)
52W Momentum 83
Distance to the 52-week high (market factor)
Net Issuance 40
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 40/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
−5.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−23.8%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+14.4%
Start year 2020 (pandemic). Over 10 years: +3.7% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−5.0%
What shareholders gained per year (last 5 years), in MYR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in MYR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−39.4%
Earnings growth per share plus dividend.
Earnings per share, growth per year−39.4%
Dividend (yield on the price)0.0%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.35% → 17%
⚠ Revenue per share shrinking 27.1%/yr over ~6Y (margin trend unclear) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.

9113 screens 202% overvalued. Compare with Intuitive Surgical, Inc →

Compare Iconic Worldwide Bhd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Instruments & Supplies · 203 stocks

Beats the industry median on 4/10 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 37 · Bottom 25%
Fair Value upside −65% · Bottom 25%
Profitability
Return on assets 2% · Below median
Net margin (TTM) −3% · Bottom 25%
Operating margin (TTM) −1% · Bottom 25%
Growth and dividend
Revenue growth 28% · Top 25%
Balance sheet
Debt / equity 0.41× · Highest 25%

Valuation Multiplesvs Medical Instruments & Supplies median · lower = cheaper

P/B 0.19× · Cheapest 25%
P/S (TTM) 0.61× · Cheapest 25%
EV/EBITDA 8.1× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 17
FUTURE (revenue growth)100 · sector 31
PAST (return on equity)0 · sector 25
HEALTH (low debt)80 · sector 96
DIVIDEND (yield)0 · sector 33

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Intuitive Surgical, Inc ISRG $402.09 $353.38 −12%
EssilorLuxottica Société anonyme EL €144.70 €159.17 +10%
Medline Inc MDLN $34.30 $30.15 −12%
Becton, Dickinson and Company BDX $182.52 $103.53 −43%
Alcon Inc ALC $65.39 $39.78 −39%
ResMed Inc RMD A$31.70 A$34.87 +10%
West Pharmaceutical Services, Inc WST $375.87 $137.28 −63%
Sartorius Stedim Biotech S.A DIM €215.80 €54.82 −75%
Straumann Holding STMN CHF 96.38 CHF 45.50 −53%
Solventum Corporation SOLV $88.75 $130.51 +47%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Iconic Worldwide Bhd Fair Value". https://www.fairvalue-calculator.com/stock/9113

Frequently asked questions

Is Iconic Worldwide Bhd (9113) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 0.0298 MYR versus a price of 0.0900 MYR, about −67% upside (overvalued).
What is the fair value of 9113?
Our model-based fair value for Iconic Worldwide Bhd is 0.0298 MYR (as of Sep 24, 2026), built from audited fundamentals. The current price: 0.0900 MYR.
What is the quality score of 9113?
Iconic Worldwide Bhd has a Quality Score of 37/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Iconic Worldwide Bhd (9113)?
Our model-based price target is the fair value of 0.0298 MYR (as of Sep 24, 2026) from 13 valuation models. Cautious scenario 0.0213 MYR, optimistic scenario 0.0468 MYR. It is a calculation from audited fundamentals, not an analyst target.
What is the Iconic Worldwide Bhd stock forecast for 2026?
Our models put fair value at 0.0298 MYR, about −67% upside versus a price of 0.0900 MYR (overvalued). Cautious scenario 0.0213 MYR, optimistic scenario 0.0468 MYR. The calculation is refreshed regularly with new filings.
What is the revenue of Iconic Worldwide Bhd (9113)?
Iconic Worldwide Bhd reported trailing-twelve-month revenue of about 57.7M MYR (latest available figure, as of Sep 24, 2026).
What is the intrinsic value of Iconic Worldwide Bhd (9113)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Iconic Worldwide Bhd it is 0.0298 MYR per share (as of Sep 24, 2026), against a price of 0.0900 MYR. It is the blended result of 13 valuation models (cash flow, earnings, asset, dividend).
Is Iconic Worldwide Bhd stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 9113 trades above its calculated fair value: price 0.0900 MYR, fair value 0.0298 MYR, a gap of about −67% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 9113?
No. The price is what the market pays today (0.0900 MYR); the fair value is what the company's own numbers justify (0.0298 MYR). For Iconic Worldwide Bhd the two are 0.0602 MYR per share apart. That gap is exactly why we show both numbers side by side.
How much is Iconic Worldwide Bhd worth?
The market values Iconic Worldwide Bhd at about 152M MYR (market capitalisation, as of Sep 24, 2026). Per share that is 0.0900 MYR; our models calculate a fair value of 0.0298 MYR per share.
What do the bullish and bearish scenarios say about 9113?
Our models span a range for Iconic Worldwide Bhd: cautious scenario 0.0213 MYR, base 0.0298 MYR, optimistic 0.0468 MYR per share (as of Sep 24, 2026, price 0.0900 MYR). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Iconic Worldwide Bhd (9113)?
Balance-sheet figures for Iconic Worldwide Bhd (as of Sep 24, 2026): return on equity −1.0%, debt of 0.41 per unit of equity. They feed the Quality Score of 37/100, which measures business quality independently of the share price.
How far is 9113 from its 52-week high?
Iconic Worldwide Bhd trades at 0.0900 MYR, at its 52-week high of 0.0900 MYR and 50% above the low of 0.0600 MYR (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of 0.0298 MYR is for.
Which stocks are comparable to Iconic Worldwide Bhd?
From the same area (Healthcare) we also value Intuitive Surgical, Inc, EssilorLuxottica Société anonyme, Medline Inc, Becton, Dickinson and Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Iconic Worldwide Bhd stock attractive at the current price?
The data as of Sep 24, 2026: price 0.0900 MYR, calculated fair value 0.0298 MYR (−67%), Quality Score 37/100, from 13 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 9113 calculated?
We run Iconic Worldwide Bhd through 13 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 0.0298 MYR, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. Iconic Worldwide Bhd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Iconic Worldwide Bhd (9113)?
The closing price on Sep 24, 2026 was 0.0900 MYR. Our model-based fair value is 0.0298 MYR, about −67% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Iconic Worldwide Bhd right now?
The price sits above even our optimistic bull case (0.0468 MYR). The favourable scenario is already priced in. Weak quality (37/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range (0.0213 MYR to 0.0468 MYR) leaves room in how you read the outcome.

Key figures of Iconic Worldwide Bhd

How large is the market capitalisation of Iconic Worldwide Bhd (9113)?
The market capitalisation of Iconic Worldwide Bhd is 152M MYR (≈ $37.2M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Iconic Worldwide Bhd (9113)?
The price-to-sales ratio of Iconic Worldwide Bhd is 1.90 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of Iconic Worldwide Bhd (9113)?
The net margin of Iconic Worldwide Bhd is 6.6% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Iconic Worldwide Bhd (9113)?
The return on equity (ROE) of Iconic Worldwide Bhd is −1.0% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Iconic Worldwide Bhd (9113)?
On an EBIT basis the return on assets of Iconic Worldwide Bhd is −6.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Iconic Worldwide Bhd (9113)?
The operating margin of Iconic Worldwide Bhd is −0.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Iconic Worldwide Bhd (9113)?
Revenue at Iconic Worldwide Bhd is growing +28.2% versus a year earlier (3y avg −23.8%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Iconic Worldwide Bhd (9113) generate?
The free cash flow of Iconic Worldwide Bhd is −18.3M MYR (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Iconic Worldwide Bhd (9113) carry?
The net debt of Iconic Worldwide Bhd is 72.7M MYR (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Iconic Worldwide Bhd in the live analysis

One click puts Iconic Worldwide Bhd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.